Literature DB >> 8095318

Q pili enhance the attachment of Moraxella bovis to bovine corneas in vitro.

W W Ruehl1, C Marrs, M K Beard, V Shokooki, J R Hinojoza, S Banks, D Bieber, J S Mattick.   

Abstract

Moraxella bovis, the causative agent of infectious bovine keratoconjunctivitis, exhibits several virulence factors, including pili, haemolysin, leukotoxin, and proteases. The pili are filamentous appendages which mediate bacterial adherence. Prior studies have shown that Q-piliated M. bovis Epp63 are more infectious and more pathogenic than I-piliated and non-piliated isogenic variants, suggesting that Q pili per se, or traits associated with Q-pilin expression, promote the early association of Q-piliated bacteria with bovine corneal tissue. In order to better evaluate the role of Q pili in M. bovis attachment, several M. bovis strains and a recombinant P. aeruginosa strain which elaborates M. bovis Q pili but not P. aeruginosa PAK pili, were evaluated using an in vitro corneal attachment assay. For each strain tested, piliated organisms attached better than non-piliated bacteria. M. bovis Epp63 Q-piliated bacteria adhered better than either the I-piliated or non-piliated isogenic variants. Finally, recombinant P. aeruginosa organisms elaborating M. bovis Q pili adhered better than the parent P. aeruginosa strain which did not produce M. bovis pili. These results indicate that the presence of pili, especially Q pili, enhances the attachment of bacteria to bovine cornea in vitro.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8095318     DOI: 10.1111/j.1365-2958.1993.tb01119.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  10 in total

Review 1.  Type IV pilin proteins: versatile molecular modules.

Authors:  Carmen L Giltner; Ylan Nguyen; Lori L Burrows
Journal:  Microbiol Mol Biol Rev       Date:  2012-12       Impact factor: 11.056

2.  Ocular immune responses in steers following intranasal vaccination with recombinant Moraxella bovis cytotoxin adjuvanted with polyacrylic acid.

Authors:  John A Angelos; Judy M Edman; Munashe Chigerwe
Journal:  Clin Vaccine Immunol       Date:  2013-12-11

3.  Assessment of Bdellovibrio bacteriovorus 109J killing of Moraxella bovis in an in vitro model of infectious bovine keratoconjunctivitis.

Authors:  Mélanie J Boileau; Kenneth D Clinkenbeard; John J Iandolo
Journal:  Can J Vet Res       Date:  2011-10       Impact factor: 1.310

4.  Transcriptional regulation of type 4 pilin genes and the site-specific recombinase gene, piv, in Moraxella lacunata and Moraxella bovis.

Authors:  D W Heinrich; A C Glasgow
Journal:  J Bacteriol       Date:  1997-12       Impact factor: 3.490

5.  Complementation analysis of the Dichelobacter nodosus fimN, fimO, and fimP genes in Pseudomonas aeruginosa and transcriptional analysis of the fimNOP gene region.

Authors:  J L Johnston; S J Billington; V Haring; J I Rood
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

6.  Recombinant Moraxella bovoculi cytotoxin-ISCOM matrix adjuvanted vaccine to prevent naturally occurring infectious bovine keratoconjunctivitis.

Authors:  John A Angelos; V Michael Lane; Louise M Ball; John F Hess
Journal:  Vet Res Commun       Date:  2010-03-10       Impact factor: 2.459

7.  Amino acid sequence homology between Piv, an essential protein in site-specific DNA inversion in Moraxella lacunata, and transposases of an unusual family of insertion elements.

Authors:  A G Lenich; A C Glasgow
Journal:  J Bacteriol       Date:  1994-07       Impact factor: 3.490

8.  Relatedness of type IV pilin PilA amongst geographically diverse Moraxella bovoculi isolated from cattle with infectious bovine keratoconjunctivitis.

Authors:  John A Angelos; Kristin A Clothier; Regina L Agulto; Boguslav Mandzyuk; Morten Tryland
Journal:  J Med Microbiol       Date:  2021-02       Impact factor: 2.472

9.  Involvement of Type IV Pili in Pathogenicity of Plant Pathogenic Bacteria.

Authors:  Saul Burdman; Ofir Bahar; Jennifer K Parker; Leonardo De La Fuente
Journal:  Genes (Basel)       Date:  2011-10-18       Impact factor: 4.096

10.  A Five Year Randomized Controlled Trial to Assess the Efficacy and Antibody Responses to a Commercial and Autogenous Vaccine for the Prevention of Infectious Bovine Keratoconjunctivitis.

Authors:  Matthew M Hille; Matthew L Spangler; Michael L Clawson; Kelly D Heath; Hiep L X Vu; Rachel E S Rogers; John Dustin Loy
Journal:  Vaccines (Basel)       Date:  2022-06-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.